Makana Therapeutics Team

Joe Tector, MD, PhD, FACS

Joe Tector, MD, PhD, FACS

Founder

More than 30 years of experience in transplant surgery and as Director, Xenotransplant Institute; Surgical Director, Small Bowel and Multivisceral Transplant Program, University of Miami Medical School. Dr. Tector received his training from McGill University, University of Miami, and St Louis University School of Medicine.
Mark Platt

Mark Platt

President & CEO

Platt has 34 years of experience in business and organizational leadership with strong background in manufacturing, engineering, hospital administration, sales, marketing and product development. Former Pres/CEO of Multistack, SVP at Gundersen Health System, Gundersen Board of Trustees, Combat Engineering Officer-U.S. Air Force Reserve. B.S. – Electrical Engineering and Mathematics, Vanderbilt University.
Matt Tector, PhD

Matt Tector, PhD

Chief Scientific Officer

Prior to joining Makana oversaw the creation and validation of the TKO pig and xenotransplant-related histocompatibility assays.
Ed Gray

Ed Gray

Chief Operating Officer

Transplantation industry veteran with broad experience in genetic engineering, porcine development and facilities, infection disease, preclinical program design and execution, regulatory strategy and planning.
David Aberle, MBA

David Aberle, MBA

Chief Financial Officer

Aberle has 20 years experience in financial management and was the CFO at AGA Medical Corp. (Acquired by St. Jude Medical).
John Burtis, JD

John Burtis, JD

General Counsel

Burtis has 20 years of experience representing clients in complex transactional, corporate, litigation and intellectual property legal matters.
Zak Dorsey, FACHE

Zak Dorsey, FACHE

VP Business Development

Hospital Administrator with 15+ years of experience in transplant administration, practice management, managed care contracting, reimbursement, and analytics. Involved in Xenotransplant research effort for over 10 years using his experience to monetize and grow the market for this technology. He holds a Master of Health Administration degree from Indiana University.
Karl Kraebber

Karl Kraebber

VP Operations

Kraebber is a xenotransplantation and hospital operations professional with 14+ years of experience in designated pathogen free barrier facility design, animal facility operations, regulatory compliance, quality management. Prior work with Indiana University, University of Alabama. BS and MS from Purdue University in General Health Science, Technology, and Organizational Leadership.